Furthermore, we performed whole‐exome sequencing on 17 DLBCL cell lines, and CEACAM20, FMO2, GPR179, GRIPAP1, and HAT1 were identified as the most frequent mutations (Figure 5A). This evidence concerns the gene GRIPAP1 and diffuse large B-cell lymphoma.